Association between serum β2-microglobulin levels and the risk of all-cause and cardiovascular disease mortality in chinese patients undergoing maintenance hemodialysis

[1]  B. Urquhart,et al.  Uremic Toxins in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Mechanisms and Therapeutic Targets , 2021, Toxins.

[2]  J. Perl,et al.  Beta-2 microglobulin and all-cause mortality in the era of high-flux hemodialysis: results from the Dialysis Outcomes and Practice Patterns Study , 2020, Clinical kidney journal.

[3]  Rachael C. Walker,et al.  Supportive care for end-stage kidney disease: an integral part of kidney services across a range of income settings around the world. , 2020, Kidney international supplements.

[4]  A. Cheung,et al.  Markers of kidney tubule function and risk of cardiovascular disease events and mortality in the SPRINT trial. , 2019, European heart journal.

[5]  S. Lekawanvijit Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome , 2018, Toxins.

[6]  H. Fujii,et al.  Role of Uremic Toxins for Kidney, Cardiovascular, and Bone Dysfunction , 2018, Toxins.

[7]  R. Vasan,et al.  Serum β-Trace Protein and β2-Microglobulin as Predictors of ESRD, Mortality, and Cardiovascular Disease in Adults With CKD in the Chronic Renal Insufficiency Cohort (CRIC) Study. , 2016, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[8]  M. Chonchol,et al.  Recent advances in the management of hemodialysis patients: a focus on cardiovascular disease , 2014, F1000prime reports.

[9]  K. Andrassy,et al.  Comments on 'KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease'. , 2013, Kidney international.

[10]  B. Stecher,et al.  The intestinal microbiota, a leaky gut, and abnormal immunity in kidney disease. , 2013, Kidney international.

[11]  Xuemei Li,et al.  Mortality rates among prevalent hemodialysis patients in Beijing: a comparison with USRDS data. , 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  H. Kim,et al.  Higher serum beta2-microglobulin levels are associated with better survival in chronic hemodialysis patients: a reverse epidemiology. , 2011, Clinical Nephrology.

[13]  À. Argilés,et al.  Levels of circulating endothelial progenitor cells are related to uremic toxins and vascular injury in hemodialysis patients , 2009, Journal of thrombosis and haemostasis : JTH.

[14]  M. Inaba,et al.  Serum beta2-microglobulin level is a significant predictor of mortality in maintenance haemodialysis patients. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  J. Jankowski,et al.  A bench to bedside view of uremic toxins. , 2008, Journal of the American Society of Nephrology : JASN.

[16]  K. Farrington,et al.  Relative Importance of Residual Renal Function and Convection in Determining Beta-2-Microglobulin Levels in High-Flux Haemodialysis and On-Line Haemodiafiltration , 2007, Blood Purification.

[17]  M. Haberal,et al.  Cardiac troponin I and beta 2 microglobulin as risk factors for early‐onset atherosclerosis in patients on haemodialysis , 2005, Nephrology.

[18]  D. Fliser,et al.  Uremia causes endothelial progenitor cell deficiency. , 2004, Kidney international.

[19]  Bertram L Kasiske,et al.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Circulation.

[20]  Bertram L Kasiske,et al.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. , 2003, Hypertension.

[21]  Q. Yi,et al.  Beta2-microglobulin as a potential initiator of inflammatory responses. , 2003, Trends in immunology.

[22]  Peter Stenvinkel,et al.  The elephant in uremia: oxidant stress as a unifying concept of cardiovascular disease in uremia. , 2002, Kidney international.

[23]  N. Chen,et al.  Signal transduction of beta2m-induced expression of VCAM-1 and COX-2 in synovial fibroblasts. , 2002, Kidney international.

[24]  A. Levey,et al.  Cardiovascular disease and chronic renal disease: a new paradigm. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  J. Daugirdas Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. , 1993, Journal of the American Society of Nephrology : JASN.

[26]  K. Mazanec,et al.  [Beta 2-microglobulin amyloidosis]. , 1992, Ceskoslovenska patologie.

[27]  J. Floege,et al.  Clearance and synthesis rates of beta 2-microglobulin in patients undergoing hemodialysis and in normal subjects. , 1991, The Journal of laboratory and clinical medicine.

[28]  G. Eknoyan,et al.  Association between serum 2-microglobulin level and infectious mortality in hemodialysis patients. , 2008, Clinical journal of the American Society of Nephrology : CJASN.

[29]  E. Fung,et al.  Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies. , 2007, Circulation.

[30]  William Clark,et al.  Serum beta-2 microglobulin levels predict mortality in dialysis patients: results of the HEMO study. , 2006, Journal of the American Society of Nephrology : JASN.

[31]  G. Lonnemann,et al.  Beta(2)-microglobulin amyloidosis: effects of ultrapure dialysate and type of dialyzer membrane. , 2002, Journal of the American Society of Nephrology : JASN.

[32]  H. Mano,et al.  Beta(2)-microglobulin identified as an apoptosis-inducing factor and its characterization. , 1999, Blood.

[33]  E. Appella,et al.  Beta 2-microglobulin. , 1984, Methods in enzymology.

[34]  A Vyskocil,et al.  Determination of beta 2-microglobulin in human urine and serum by latex immunoassay. , 1981, Clinical chemistry.

[35]  J. Revillard,et al.  Beta-2-microglobulin and HLA-related glycoproteins in human urine and serum. , 1981, Contributions to nephrology.